These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23253929)

  • 1. Regulatory cell subsets in the control of autoantibody production related to systemic autoimmunity.
    Fujio K; Okamura T; Sumitomo S; Yamamoto K
    Ann Rheum Dis; 2013 Apr; 72 Suppl 2():ii85-9. PubMed ID: 23253929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B cells as effectors and regulators of autoimmunity.
    Mariño E; Grey ST
    Autoimmunity; 2012 Aug; 45(5):377-87. PubMed ID: 22432804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The busy life of regulatory T cells in systemic lupus erythematosus.
    La Cava A
    Discov Med; 2009 Jun; 8(40):13-7. PubMed ID: 19772836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory B cells in ANCA-associated vasculitis.
    Wilde B; Thewissen M; Damoiseaux J; Knippenberg S; Hilhorst M; van Paassen P; Witzke O; Cohen Tervaert JW
    Ann Rheum Dis; 2013 Aug; 72(8):1416-9. PubMed ID: 23666929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human FoxP3+ regulatory T cells in systemic autoimmune diseases.
    Miyara M; Gorochov G; Ehrenstein M; Musset L; Sakaguchi S; Amoura Z
    Autoimmun Rev; 2011 Oct; 10(12):744-55. PubMed ID: 21621000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells.
    Scheinecker C; Bonelli M; Smolen JS
    J Autoimmun; 2010 Nov; 35(3):269-75. PubMed ID: 20638240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory B cells in autoimmune diseases: how do they work?
    Lemoine S; Morva A; Youinou P; Jamin C
    Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frontiers of Autoantibodies in Autoimmune Disorders: Crosstalk Between Tfh/Tfr and Regulatory B Cells.
    Ding T; Su R; Wu R; Xue H; Wang Y; Su R; Gao C; Li X; Wang C
    Front Immunol; 2021; 12():641013. PubMed ID: 33841422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T-cells and autoimmunity.
    Ni Choileain N; Redmond HP
    J Surg Res; 2006 Jan; 130(1):124-35. PubMed ID: 16154142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells in lupus.
    Kang HK; Datta SK
    Int Rev Immunol; 2006; 25(1-2):5-25. PubMed ID: 16531276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity in 2009.
    Selmi C
    Autoimmun Rev; 2010 Oct; 9(12):795-800. PubMed ID: 20716447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treg and lupus.
    Bonelli M; Smolen JS; Scheinecker C
    Ann Rheum Dis; 2010 Jan; 69 Suppl 1():i65-66. PubMed ID: 19995748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of intracellular cytokines and regulatory cells in patients with autoimmune diseases and primary immunodeficiencies - novel tool for diagnostics and patient follow-up.
    Osnes LT; Nakken B; Bodolay E; Szodoray P
    Autoimmun Rev; 2013 Aug; 12(10):967-71. PubMed ID: 23541481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting IRF4 in autoimmune diseases.
    Xu WD; Pan HF; Ye DQ; Xu Y
    Autoimmun Rev; 2012 Oct; 11(12):918-24. PubMed ID: 23010632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice.
    Scaglione BJ; Salerno E; Gala K; Pan M; Langer JA; Mostowski HS; Bauer S; Marti G; Li Y; Tsiagbe VK; Raveche ES
    J Autoimmun; 2009 Feb; 32(1):14-23. PubMed ID: 19022624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory T cells and B cells: implication on autoimmune diseases.
    Wang P; Zheng SG
    Int J Clin Exp Pathol; 2013; 6(12):2668-74. PubMed ID: 24294353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of follicular helper T cells in the absence of Treg cells: implications for loss of B-cell anergy.
    Leonardo SM; De Santis JL; Gehrand A; Malherbe LP; Gauld SB
    Eur J Immunol; 2012 Oct; 42(10):2597-607. PubMed ID: 22777796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.
    Tuve S; Chen BM; Liu Y; Cheng TL; Touré P; Sow PS; Feng Q; Kiviat N; Strauss R; Ni S; Li ZY; Roffler SR; Lieber A
    Cancer Res; 2007 Jun; 67(12):5929-39. PubMed ID: 17575163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel regulatory Th17 cells and regulatory B cells in modulating autoimmune diseases.
    Singh B; Summers KL; Kerfoot SM
    Cell Immunol; 2019 May; 339():29-32. PubMed ID: 30249342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propagation and regulation of systemic autoimmunity by gammadelta T cells.
    Peng SL; Madaio MP; Hayday AC; Craft J
    J Immunol; 1996 Dec; 157(12):5689-98. PubMed ID: 8955223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.